The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis
NCT ID: NCT07208656
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-12-15
2026-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervening to Prevent Contextual Errors in Medical Decision Making
NCT00856557
Comparing the Effect of Video-cases and Text-cases on Medical Students' Learning in Tutorial
NCT01286025
Impact of Narrative Medicine (Workshop Reading Diaries)
NCT01798290
Impact of Narrative Medicine (Workshop Reflexive Writing)
NCT01798069
Online Mindful Self-Compassion Training for Medical Students: an Exploratory Feasibility Study
NCT06538597
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study uses an open-label, two-arm randomized controlled trial design to evaluate whether exposure to a medical television drama can improve knowledge of NCC among young adults. The trial will be conducted entirely online to enable participation from a geographically diverse population and to reflect modern media consumption patterns. After providing electronic informed consent, eligible participants will be randomly assigned to either an intervention or control group in a 1:1 ratio using a computer-generated allocation process to ensure randomization integrity.
Participants in the intervention group will watch House M.D., Season 1, Episode 1 - a medically themed television episode featuring a dramatized case of parasitic brain infection with conceptual relevance to NCC. The control group will not view the episode during the study period but will be offered access to the same content after data collection is complete. Both groups will complete structured online questionnaires before and after the intervention period to measure changes in NCC-related knowledge and attitudes. These questionnaires have been developed and validated through expert review and pilot testing.
The trial's primary objective is to determine whether viewing the medical TV drama improves knowledge of NCC, as measured by changes in pre- and post-intervention knowledge scores. Secondary objectives include assessing participants' motivation to learn more about NCC and their perception of the credibility of the TV drama as an educational resource. Statistical analyses will include paired and independent t-tests (or corresponding non-parametric tests where appropriate), with significance set at p \< 0.05.
Data will be collected securely using encrypted online survey platforms. All responses will be anonymized, and no personally identifiable information will be stored. Data access will be limited to the research team, and all procedures will comply with international data protection standards.
This trial is designed in accordance with the CONSORT guidelines for randomized behavioral and educational interventions. Ethical approval has been obtained from the Research Ethics Committee of Caleb University, Nigeria, and the study will adhere to the principles outlined in the Declaration of Helsinki (1964). Participation is voluntary, and participants may withdraw at any time before data analysis without consequence.
This research is innovative in its use of entertainment-education as a vehicle for improving disease literacy. By evaluating the effect of a medical TV drama on public knowledge of NCC, the study aims to provide evidence for scalable, cost-effective, and culturally adaptable strategies for health communication in resource-limited settings. The findings are expected to contribute to global public health education efforts, particularly those addressing neglected parasitic diseases and preventable causes of epilepsy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention (House M.D. Episode)
Participants in this arm will watch a selected episode of the medical television drama House M.D. (Season 1, Episode 1), which features a dramatized case of neurocysticercosis. The intervention is designed to provide narrative-based exposure to information relevant to the disease. Participants will complete pre- and post-intervention questionnaires assessing knowledge, motivation, and credibility.
Medical TV Drama Episode (House M.D.)
Participants in the experimental group will watch a selected episode of the medical drama House M.D. (Season 1, Episode 1), which includes a dramatized storyline relevant to neurocysticercosis. The episode is intended to deliver narrative-based health education. After viewing, participants will complete post-test questionnaires assessing changes in knowledge, motivation, and credibility compared to pre-test results.
Control (No Episode)
Participants in this arm will not receive any exposure to medical television content during the study period. They will complete the same pre- and post-intervention questionnaires as the intervention group, allowing comparison of changes in knowledge, motivation, and credibility.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical TV Drama Episode (House M.D.)
Participants in the experimental group will watch a selected episode of the medical drama House M.D. (Season 1, Episode 1), which includes a dramatized storyline relevant to neurocysticercosis. The episode is intended to deliver narrative-based health education. After viewing, participants will complete post-test questionnaires assessing changes in knowledge, motivation, and credibility compared to pre-test results.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Proficient in English (reading and comprehension)
* Has access to a stable internet connection
* Possesses a screen-enabled device (e.g., smartphone, tablet, or computer)
* Has access to the Netflix streaming platform
Exclusion Criteria
* Has a prior diagnosis of neurocysticercosis (NCC)
* Has previously participated in any NCC-related health literacy or awareness program
* Lacks access to the Netflix movie platform
* Below 18 years or above 35 years of age
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cephas Health Research Initiative Inc, Ibadan, Nigeria
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emeka Okeke
Dr.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CUL25/NCC/001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.